Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00867243 · ClinicalTrials.gov registry record
Prediction of Hepatitis C Recurrence in Liver Transplant Recipients
A clinical trial, sponsored by Northwestern University.
- Terminated
- Registry status
- 24
- Enrollment target
NCT00867243: Clinical Trial study, sponsored by Northwestern University.
NCT00867243 is a clinical trial that was terminated before completion, run by Northwestern University. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00867243 was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of the study is to look at cells of the immune system to see if the cells are different among people with different risk factors that have received a liver transplant. We will enroll 50 patients receiving liver transplant and their donors. Both donor and recipient must participate in the order for the recipient to participate in the study. We will take blood samples from these patients and their donors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2005-10 |
| Est. Completion | 2011-05 |
Why NCT00867243 stopped before completion
NCT00867243 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00867243 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00867243 about?
NCT00867243 is a clinical study titled "Prediction of Hepatitis C Recurrence in Liver Transplant Recipients". The purpose of the study is to look at cells of the immune system to see if the cells are different among people with different risk factors that have received a liver transplant. We will enroll 50 patients receiving liver transplant and their donors. Both donor and recipient must participate in the...
What is the current status of trial NCT00867243?
This trial is currently terminated. The enrollment target is 24 participants. The study started on 2005-10. Estimated completion is 2011-05.
Who is sponsoring clinical trial NCT00867243?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia